E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Timing of and Risk Factors for Myocardial Ischemic Events After Percutaneous Coronary Intervention (IMPACT-II)
Mark C. Thel,Robert M. Califf,Barbara E. Tardiff,Laura H. Gardner,Kristina N. Sigmon,A. Michael Lincoff,Eric J. Topol,Michael M. Kitt,James C. Blankenship,James E. Tcheng +9 more
TL;DR: The risk of ischemic events were greatest immediately after PCI and rapidly declined, so that by 9 hours the hazard function plot was flat; 66% of events occurred within 6 hours of PCI.
Journal ArticleDOI
Restenosis—an open file
TL;DR: With increased understanding of the restenotic process and continued refinement of effective treatments, it may be possible one day to prevent stenosis recurrence and provide more pharmacologic and mechanical therapies targeting restenosis.
Journal ArticleDOI
Prehospital administration of aspirin in patients with unstable angina and acute myocardial infarction.
Mark J. Eisenberg,Eric J. Topol +1 more
TL;DR: Since the potential benefits are great and the risks and costs are low, physicians should encourage the prehospital administration of aspirin in patients with symptoms suggestive of unstable angina or acute myocardial infarction.
Journal ArticleDOI
Operation Nasal Vaccine—Lightning speed to counter COVID-19
Eric J. Topol,Akiko Iwasaki +1 more
TL;DR: Given the poor ability of intramuscular mRNA COVID-19 vaccines to induce robust immunity in the respiratory mucosa, a push for a nasal vaccine strategy is needed.
Journal ArticleDOI
Assessment of Coronary Reperfusion After Thrombolysis With a Model Combining Myoglobin, Creatine Kinase–MB, and Clinical Variables
Robert H. Christenson,Erik Magnus Ohman,Eric J. Topol,Steven L. Peck,L K Newby,Show-Hong Duh,Dean J. Kereiakes,Seth J. Worley,G L Alosozana,Thomas C. Wall,Robert M. Califf +10 more
TL;DR: A single myoglobin measurement obtained 90 minutes after the start of thrombolysis, combined with select clinical variables and creatine kinase-MB levels, enhances the noninvasive prediction of reperfusion after myocardial infarction.